“It’s not that I was categorically opposed to the idea of scientists and physicians using gene editing to introduce heritable changes into… — Jennifer A. Doudna Copy Share Image
“Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies” — Jennifer A. Doudna Copy Share Image
“PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of… — Jennifer A. Doudna Copy Share Image
“in 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.” — Jennifer A. Doudna Copy Share Image
“we founded Editas Medicine with $43 million in financing from three venture capital firms.” — Jennifer A. Doudna Copy Share Image
“It’s not that I was categorically opposed to the idea of scientists and physicians using gene editing to introduce heritable changes into the human… — Jennifer A. Doudna Copy Share Image
“Editas Medicine has an exclusive multimillion-dollar license with Juno Therapeutics to develop T cell therapies” — Jennifer A. Doudna Copy Share Image
“I'd recently co-founded an institute in the Bay Area called the Innovative Genomics Institute (ICI) with the goal of advancing gene-editing technologies.” — Jennifer A. Doudna Copy Share Image
“PGD has also been used for other controversial purposes, such as the birth if so-called savior siblings, destined from the moment of implantation not… — Jennifer A. Doudna Copy Share Image
“in 2011, Rachel and I founded a company called Caribou Biosciences to commercialize the Cas proteins.” — Jennifer A. Doudna Copy Share Image
“human gene editing would almost assuredly never have the same catastrophic consequences as the detonation of a nuclear weapon” — Jennifer A. Doudna Copy Share Image
“American spy agencies seemed rattled by the experiments too. I was shocked when the next Worldwide Threat Assessment — the annual report presented by… — Jennifer A. Doudna Copy Share Image
“As we began discussing authorship of a white paper summarizing our conclusions, we debated who our target audience should be and what kind of… — Jennifer A. Doudna Copy Share Image
“have no doubt, this technology will — someday, somewhere — be used to change the genome of our own species in ways that are… — Jennifer A. Doudna Copy Share Image
“every single CRISPR region had expanded to include a new snippet of DNA spliced between the repeats. Furthermore, these new spacers perfectly matched the… — Jennifer A. Doudna Copy Share Image
“improving on the natural course if evolution—which, attendees argued, could be so cruel as to justify some sort of intervention.” — Jennifer A. Doudna Copy Share Image
